john hawks weblog

paleoanthropology, genetics and evolution

disease

  • Fatigued by advocates impeding research

    Sun, 2010-07-04 11:55 -- John Hawks

    Science has a news article that details the conflict over publishing new research on a viral cause of chronic fatigue syndrome (CFS): "Conflicting Papers on Hold as XMRV Frenzy Reaches New Heights".

    It's mainly about the conflicting results of several ongoing studies into whether there is a virus-disease association. Early stages for serious research, and there is as yet little idea of the mechanism that might be involved. But even here, there are big disagreements:

    Science has learned that a paper describing the new findings, already accepted by the Proceedings of the National Academy of Sciences (PNAS), has been put on hold because it directly contradicts another as-yet-unpublished study by a third government agency, the U.S. Centers for Disease Control and Prevention (CDC). That paper, a retrovirus scientist says, has been submitted to Retrovirology and is also on hold; it fails to find a link between the xenotropic murine leukemia virus-related virus (XMRV) and CFS. The contradiction has caused "nervousness" both at PNAS and among senior officials within the Department of Health and Human Services, of which all three agencies are part, says one scientist with inside knowledge.

    I'm pointing to the story because I was interested in the last few paragraphs. CFS sufferers and advocates are eager to see progress toward understanding the disease. This creates pressure on researchers -- especially those who fail to find evidence for this hypothesis:

    Patients have become a loud voice in the scientific debate as well—and it's taking its toll on scientists who don't support the XMRV hypothesis. "It's ghastly, " says retrovirologist Myra McClure of Imperial College London, the lead author on one of the three published studies that came up empty-handed. "I've had people writing me, and I quote, that I don't know my arse from my elbow, and that I should be fired." Four months after her first paper on CFS came out, McClure says it was also her last one. "Nothing on God's Earth could persuade me to do more research on CFS, " she says. "I feel bad for the scientists, because it's true, we are a very angry community, " says Wilhelmina Jenkins, a physicist living in Atlanta who has had CFS since 1983.

    I think in general unrecognized pathogens are likely causes of disorders like CFS, and I agree that researchers for too long failed even to look seriously at them. Yet, there's a lot of diagnostic noise complicating things -- does everyone diagnosed with CFS really have the same condition? -- and for chronic conditions the science is always difficult. A giant epidemiological study may increase the statistical power, but it also vastly increases the political fighting.

    Of course, they write me and tell me I don't know my arse from my elbow, either. I guess you gotta have a thick skin if you're going to deny that ancient aliens directed our evolution!

  • Smallpox vaccine and HIV

    Mon, 2010-05-17 23:07 -- John Hawks

    A new paper claims that HIV infection may be impeded in individuals who had the smallpox vaccine:

    [Dr. Raymond] Weinstein and his colleagues analyzed the behavior of white blood cells sampled from patients recently immunized with the smallpox vaccine.

    They found that after exposure to HIV, cells from immunized individuals were five times less likely to allow for HIV replication than the same cells taken from non-immunized patients.

    This is presumably a relatively small effect on HIV transmission, although the story hypes it as a reason for differential infection rates in Africa. What I wonder is whether the observation enhances the hypothesis that CCR5 delta-32, the HIV resistance allele, once functioned as a smallpox defense.

  • Sickle cell chimeras

    Thu, 2009-12-10 07:30 -- John Hawks

    Many of us use sickle cell as an example in classes. I always do so while noting the progress that has been made in treating the condition in Westernized contexts -- otherwise students walk away with a very misleading view of today's medical situation for patients expressing the sickle trait.

    The news today is full of a new advance in treatment -- it's stem cell transplants in bone marrow, and the new aspect is a better protocol for adult sufferers (children have benefited from these transplants for some time).

    I'll link to the research paper's abstract instead of a news story:

    Conclusions: A protocol for nonmyeloablative allogeneic hematopoietic stem-cell transplantation that includes total-body irradiation and treatment with alemtuzumab and sirolimus can achieve stable, mixed donor–recipient chimerism and reverse the sickle cell phenotype.

    You've got to like a treatment where the desired outcome is "chimerism."

  • Dracunculiasis

    Mon, 2009-12-07 19:14 -- John Hawks

    The NYT reports that Nigeria has been free of guinea worm infections for a year.

    Guinea worm — or dracunculiasis — inspires universal horror. People are stricken when they drink pond water infested with microscopic fleas, in which the worm larvae live. The worms grow to resemble translucent three-foot strands of spaghetti and finally emerge by exuding acid that bursts the skin; the pain can be crippling for months.

    Only four countries — Ethiopia, Ghana, Mali and Sudan — still have the worms. About 3,000 of them were found as of last month, down from three million across the globe when Mr. Carter began his effort to wipe them out.

    The WHO page on dracunculiasis eradication doesn't give many more details. A lot more information can be found in a review by Cairncross and colleagues (2002), the complete text of which is free on PubMed. I went looking out of curiosity about animal infections -- it seems too easy to get rid of this thing in humans, considering the presence of dracunculiasis in other mammals. North America in particular has a big problem with the parasite in carnivores -- raccoons get it a lot.

    But the human parasite is part of a larger family of nematode parasites that infect other species and often have different crustacean hosts. There seems to be occasional transfer into humans of various other forms, and transfer of the human parasite into domesticated animals, but access to filtered water is sufficient to break the human cycle. In several countries where human dracunculiasis was eliminated many decades ago, it hasn't returned, so the simple effort to provide clean water seems sufficient to eradicate it.

    References:

    Cairncross S, Muller R, Zagaria N. 2002. Dracunculiasis (Guinea Worm Disease) and the Eradication Initiative. Clin Microbiol Rev 15:223-246. doi:10.1128/CMR.15.2.223-246.2002

  • Leprosy evolution in humans

    Fri, 2009-11-27 02:59 -- John Hawks

    Where did leprosy come from as a human pathogen, and how did it spread through the world? Two years ago, this new research would have merited a whole book. Now it's all packed into a single Nature Genetics paper by Marc Monot and coworkers.

    I mean, there's a lot in here:

    1. They used next-gen sequencing platforms to get three additional whole-genome sequences for the pathogen that causes leprosy, Mycotuberculum leprae.

    2. By comparing the different strains together with an already-available one, representing patients in four countries, they measured the genome diversity and found SNPs between strains.

    3. They then genotyped the resulting SNPs in 400 isolates, building a phylogeny of worldwide strains of M. leprae today.

    4. They did a phylogeographic analysis of the strains, testing hypotheses about past transfers of the bacterium among regions.

    5. And then, on top of all that, they recovered skeletal remains from "leprosy graveyards" in six countries, diagnosed the skeletal correlates of leprosy in 13 cases and genotyped the resulting extracts for M. leprae, placing them on the global phylogenetic tree.

    Whew!

    Well, I assume that the skeletal work was done separately, with samples being sent to the lab folks to do their DNA extraction.

    This would be a really good topic for a documentary. There's all the historical information about leprosy to draw upon, including of course its prominent appearance in the Bible and Father Damien. There's the triumph of effective treatments in developed parts of the world -- an aspect that this paper emphasizes, as it attempted to find out whether regions of the world that now lack M. leprae once had the strains expected from their geographic placement. And there's the continuing tragedy of the disease in many less developed parts of the world, with the need to deliver treatment more effectively. Meanwhile, the phylogeographic aspects of this paper provide another historical angle, about the spread of leprosy around the world on human trade routes.

    Plus there's the whole mystery of how it got into humans in the first place:

    Finally, it is worth discussing the enormous discrepancy between the period at which pseudogene formation is thought to have arisen and the origin of early humans. It has been estimated recently that the bulk of the pseudogenes in M. leprae arose no earlier than 9 million years ago. Pseudogene formation is an indicator of radical change in the lifestyle of the host bacterium, such as from the free-living to pathogenic state or of adaptation to life within a particular tissue or cell type. In the case of M. leprae, obligate parasitism of humans or another primate species would represent such a change. Although modern humans represented by H. sapiens have existed only since approximately 250,000 years ago and left Africa within the last 100,000 years to settle other regions, earlier hominids are thought to have diverged from chimpanzees over 5 million years ago. Reconciliation of the estimated time of pseudogene formation with human evolution could be achieved if an ancestor of M. leprae infected an early primate and then underwent genome decay and was subsequently transmitted vertically—although this seems unlikely, given that more genetic diversity among M. leprae isolates would be expected if this were true. Alternatively, the genome decay could well be ancient, but M. leprae may only recently have become a human pathogen. For instance, it is conceivable that an ancestral form of M. leprae infected an invertebrate host such as an insect, which later acted as a vector for transmitting the bacillus to humans. Support for the latter scenario is provided by studies of the related pathogen Mycobacterium ulcerans, which is at an early stage of reductive evolution and appears to be transmitted to humans by water bugs and/or mosquitoes. Further insight into the timing of pseudogene formation in M. leprae will be provided by microbiology and paleomicrobiology and by deeper genome sequence analysis.

    In rough outline, you "date" a pseudogene by counting the number of nonsynonymous substitutions in comparison to some other species where the gene is functional. When the gene was functional, most substitutions of nonsynonymous mutations would have been prevented by purifying selection. You generally apply more detailed assumptions, but that's the basic process. I raise the point because dating a 9-million-year-old event in a bacterial species on the basis of nonsynonymous mutations is probably not going to give a very tight confidence interval, to put it charitably. Maybe 9 million is 4 million?

    In any event, leprosy is one more addition to a growing story about the coevolution of pathogens with Homo. It may have a long history with us, like its congener, tuberculosis. It apparently doesn't have a long history of coevolution within different regionally variable human populations -- tuberculosis does. Possibly it is a relatively recent invasion from another species, which would make it maybe more like the evolutionary dynamics of vivax malaria.

    We don't lack for examples, and tabulating the histories of all of these pathogens may give us a better picture of the population ecology of Homo in Pleistocene times.

    References:

    Monot M and many others. 2009. Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nat Genet 41:1282-1289. doi:10.1038/ng.477

  • Flu blues

    Wed, 2009-10-21 00:45 -- John Hawks

    Will the swine flu lead to the next big evolutionary change for humans? No. But it has already begun to affect the way people interact with each other. I wandered onto campus a couple of weeks ago and saw people wearing face masks! We've been asked to plan for our "essential" classes in the event of a pandemic.

    It's a good time to be on leave. But my kids' school has been closed the rest of the week. It's the flu -- more than a third of the whole school was out sick yesterday.

    In the August Smithsonian magazine, writer Rob Dunn discussed a hypothesis that tries to relate cultural diversity and xenophobia (fear of the other) to the rate of infectious disease ("The culture of being rude"):

    In a series of high-profile papers, Corey Fincher and Randy Thornhill, both at the University of New Mexico, and Mark Schaller and Damian Murray of the University of British Columbia argue that one factor, disease, ultimately determines much of who we are and how we behave.

    Their theory is simple. Where diseases are common, individuals are mean to strangers. Strangers may carry new diseases and so one would do best to avoid them. When people avoid strangers—those outside the tribe—communication among tribes breaks down. That breakdown allows peoples, through time, to become more different.

    Differences accumulate until in places with more diseases, for example Nigeria or Brazil, there are more cultures and languages. Sweden, for example, has few diseases and only 15 languages; Ghana, which is a similar size, has many diseases and 89 languages. Cultural diversity is, in this view, a consequence of disease.

    On the surface, this seems a poor example -- the population has been thin in Sweden relative to Ghana for most of the last 6000 years, until the rise of the Swedish state. It's no surprise that a recent population expansion coupled with political centralization would result in a relatively uniform language and culture area.

    But as the article goes on to explain, some of the theorists think that the rise of states is itself a dependent variable. They would propose that the growth of polities was limited in Ghana because of a high disease load, retaining and fostering a cultural diversity that would have been wiped out by natural political consolidation in a less-disease-prone region of the world.

    That's the logic, at least.

    This kind of topic is interesting but endlessly frustrating. The frustration -- at least for me -- comes from the ready confusion of biological and cultural processes of change. Dunn's article says as much:

    As a rule, it is good to be skeptical of biologists who, like Fincher and Thornhill, propose to explain a whole bunch of things with one simple theory. More so when those biologists are dabbling in questions long reserved for cultural anthropologists, who devote their careers to documenting and understanding differences among cultures and their great richness of particulars. Biologists, and I am no exception, seem to have a willingness–or even need—to see generalities in particulars. Fincher’s new theory would offer an example of these desires (and a little hubris) run amok, of biologists seeing the entire history of human culture through one narrow lens. It would offer such an example, if it didn’t also seem, quite possibly, right.

    As a rule, I'm skeptical of everything. "Wary of strangers" wouldn't keep our school open -- those kids are all catching the flu from their friends. It doesn't take very many contacts between groups of people to spread an epidemic far and wide.

    In that respect, it's a problem for percolation theory. You've got a network of people through which the flu can be transmitted. If the people tend to be highly interconnected, with each other, the flu spreads widely. But even if links between groups are rare, the strong interconnections within a group can keep the epidemic alive long enough to make it to the next hop. At some critical level, the links are no longer enough, and the pathogen can't propagate.

    So does it do you personally much good to be wary of strangers, if you have a few cosmopolitan friends? Everything can make a little difference to the percolation network, but it seems to me that people carrying the "xenophobia" gene would still maintain large social networks including a few people who interacted far and wide with strangers. It's not that the direction of the effect is wrong; it's that a wholesale elimination of stranger contact by an individual may have little effect on her probability of infection, since friends may have gotten the pathogen from strangers.

    It's awful hard for a "xenophobia" gene to get going in that scenario.

  • HIV from gorillas

    Wed, 2009-08-05 00:32 -- John Hawks

    A new strain of HIV has come from gorillas: "New Strain of H.I.V. Is Discovered"

    All three other known strains of the human immunodeficiency virus, H.I.V.-1, have been linked to chimpanzees. But genetic tests showed that the new virus was closely related to a recently recognized gorilla virus.

    The most likely explanation for the new virus’s emergence is gorilla-to-human transmission, probably a result of humans slaughtering apes or handling or eating their meat.

  • Primate genomics: the Duffy (FY) gene, malaria, and baboons

    Wed, 2009-06-24 20:55 -- John Hawks

    Jenny Tung of Duke University and colleagues report in Nature (online early) that yellow baboons have evolved a Duffy antigen-related defense against a baboon relative of malaria.

    Most Africans carry a null allele for the Duffy antigen, coded by the DARC gene, which functions to protect them from vivax malaria. It's not the worst kind of malaria (that would be falciparum), but it is a major cause of disease outside those regions where the Fy*O allele is near fixation.

    The baboon version of DARC is not convergent with the human null allele; the paper reports that it actually increases the gene activity, whereas the baboon variant allele actually increases the activity.

    Presumably, the different defense in baboons is because they're fighting a different parasite:

    Baboons are not generally infected by Plasmodium in the wild, but are vulnerable to infection by several closely related haematoprotozoans (4, 5) including Hepatocystis kochi, a blood parasite nested within the paraphyletic Plasmodium genus (15). Hepatocystis parasites do not produce the cyclical fever spikes typical of malaria in humans, but do produce anaemia and visible merocyst formation, followed by scarring on the liver (4).

    They were able to show that the infection rate with Hepatocystis is significantly lower in baboons that cary the protective allele.

    Based on their comparisons, the locus looks like a case of balancing selection:

    We detected an increased level of population differentiation among East African baboon populations around FY, by comparing a FY-linked microsatellite with 35 neutral microsatellites (Fst = 0.31, P Fst for the neutral markers was 0.008–0.346; Fst is a metric describing genetic divergence between populations based on allele frequency differences at variable sites; Supplementary Fig. 3). We also detected a higher value for the Tajima's D statistic (D = 1.26) in this region relative to nine of nine other resequenced putative cis-regulatory regions in the Amboseli population and 11 of 12 resequenced transcribed regions (range of D for all other loci was -1.60 to 2.12). The only locus with a higher value of D, a transcribed portion of the gene MSR1, exhibited an even more extreme value than that identified for the MHC DQA1 promoter in baboons (22), which is known to evolve under strong trans-specific balancing selection (20).

    A balance really would be necessary for them to be likely to have any evidence of selection. There's no reason to think that baboons are in the kind of demographic and disease transient that humans are in, so if a protective allele were always beneficial, it would likely be fixed. Still, it's not obvious what the disadvantage of the protective allele would be, although in humans it has been suggested that altering Duffy expression may impair immune response by reducing white blood cell count (Reich et al. 2009). Considering the high stress and cortisol levels of wild baboons, it may be that changes in immune activity have even more disadvantages.

    One important aspect of the study is that the allele affects the cis-regulatory region of the gene; that's the general research topic covered by Gregory Wray's research group. I think that it's important because it raises the prospect that targeted sequencing of cis-regulatory elements in primate genomes might lead to the discovery of more adaptive variations within primate species. In their concluding paragraph, the authors emphasize the strengths of a combined field and in vitro approach to characterizing functional variants:

    In vivo gene expression measurements are complicated by variation in genetic background and in the environment, both of which can modify functional cis-regulatory effects (25, 26). Indeed, our results show that even baboons that are homozygotes at the C/T site sometimes exhibit allelic imbalance in FY expression, suggesting that other, unidentified functional cis-regulatory variants are also segregating in the population. In contrast, in the in vitro comparisons, only a single cis-regulatory site differed between the experimental constructs, thus controlling for both environment and genetic backgrounds. Using both approaches in tandem can be synergistic: while in vitro experiments can help pin down specific functional sites, in vivo results demonstrate that these effects are relevant to the biology of individuals in the wild.

    When it comes to primate genetics, looking for defenses to infectious diseases should be low-hanging fruit. Just take human genes that have alleles that defend against diseases, and sequence them for variations. Hopefully we'll find many others -- and in a few cases, those variations may prove useful in human health contexts, as they may reveal new pathways to deter or defeat pathogen infections.

    References:

    Tung J, Primus A, Bouley AJ, Severson TF, Alberts SC, Wray GA. 2009. Evolution of a malaria resistance gene in wild primates. Nature (advance online publication) doi:10.1038/nature08149

    Reich D, Nalls MA, Kao WHL, Akylbekova EL, Tandon A, et al. 2009. Reduced Neutrophil Count in People of African Descent Is Due To a Regulatory Variant in the Duffy Antigen Receptor for Chemokines Gene. PLoS Genet 5(1): e1000360. doi:10.1371/journal.pgen.1000360

  • Bigger brains, more cancer?

    Wed, 2009-06-10 14:08 -- John Hawks

    Rachael Rettner reports on a hypothesis that human cancer risk may be a side-effect of brain evolution. The hypothesis emerges from studies of gene expression, which show that regulated cell death (apoptosis) is downregulated in some human tissues:

    The researchers are tying these two hypotheses together. They think that reduced apoptosis may have helped people acquire their large brains. But it may also have made us more prone to cancer.

    "It's kind of hard to explain why we could have evolved to have a less efficient apoptotic system," says [Georgia Tech researcher John] McDonald. "So the hypothesis we came up with was that maybe selection to increase brain size was what put the selective pressure on the system to reduce apoptosis." And even though less apoptosis may have meant more cancer, there would not have been selective evolutionary pressure against it since most cancers don't appear until after reproductive age, McDonald adds.

    The article leads with the assertion that humans have more cancer than chimpanzees. Undoubtedly that's true, but I think it's a tough comparison to make. Chimpanzees in the wild only live into the bottom range of ages where humans start to have a high cancer risk. Neither captive nor wild chimpanzees have been observed in sufficient numbers to have accurate estimates of the rates of rare diseases, and captive chimpns Some cancer risk alleles, like BRCA1, hit earlier in life, but they are special cases -- rare, recent, and possibly selected for pleiotropic effects on other traits.

    No question, some species must have adaptations to reduce the incidence of cancer per cell: whales, for example, live as long or longer than humans and have vastly larger cell numbers. If they had the same cancer risk per cell, every whale would be half tumor. But humans didn't just add brain tissue, we added mass and reduced the proportion of other tissue types including muscle and gut. I'm guessing this is a more complicated issue than the simple hypothesis would suggest. Still, there's nothing impossible about it....

  • Richard Lewontin: "[T]oo rapid for genetic adaptation"

    Tue, 2009-05-26 22:56 -- John Hawks

    I have had a New York Review of Books essay by Richard Lewontin, titled, "Why Darwin?" on my desktop for a week without getting to the last section of it.

    Like many essays in the NY Review of Books, Lewontin's shoehorns small points from the books into an argument of his own. As you might guess from the title, Lewontin's theme is that Darwin has been overrated -- a result of biologists overemphasizing a "great man" story of the history of their science, and an unjustified belief in the ubiquity and power of natural selection. Lewontin mobilizes his argument against Jerry Coyne's Why Evolution Is True.

    I don't really find the "pluralist versus adaptationist" debate very interesting. Despite the vocal complaints of some, I can't ever seem to locate the mythical "adaptationists" who deny that non-adaptive evolution ever happens. So the "debate" always comes down to whether particular adaptive hypotheses are true. Since no scientific hypothesis is true a priori, and since "those adaptationists are always saying stupid things" is not a scientific argument, I don't see the point.

    Still, I meant to get to the last section of Lewontin's essay, and this morning I finally read it. To close his case for the weakness of natural selection, Lewontin turns to another new book by Greg Gibson, titled, It Takes a Genome: How a Clash Between Our Genes and Modern Life Is Making Us Sick. The book is an extended account of "diseases of civilization", a topic that I discussed here last week ("Arrested adaptation and the 'diseases of civilization'"). Here's a passage from the book's promotional material (on the Amazon page):

    In It Takes a Genome, Greg Gibson posits a revolutionary new hypothesis: Our genome is out of equilibrium, both with itself and its environment. Simply put, our genes aren’t coping well with modern culture. Our bodies were never designed to subsist on fat and sugary foods; our immune systems weren’t designed for today’s clean, bland environments; our minds weren’t designed to process hard-edged, artificial electronic inputs from dawn ‘til midnight. And that’s why so many of us suffer from chronic diseases that barely touched our ancestors.

    Set aside for a moment how "revolutionary" this hypothesis is -- I'll revisit the idea in another post. The question is whether this mismatch between our environments and our genetic variation means that human evolution "stopped" or that we are still "adapted to the Pleistocene". As I pointed out in my earlier post, both propositions are true: human populations are mismatched with their current environments, and human populations have been recently adapting very rapidly to new environments. Here's what I wrote last week:

    [M]any of today's chronic diseases reflect the reaction of human biology to novel environments for which our genes are not well adapted. But we don't need to exaggerate the slowness of human evolution to arrive at that conclusion. Recent rapid evolution of humans does not mean that humans are perfectly adapted to the present. Far from it -- if human populations have undergone rapid genetic changes into the past thousand years, it is a strong sign that fitness has not yet maximized in the post-agricultural environment.

    I can contrast my point of view with Richard Lewontin's, who perfectly reiterates the "human evolution stopped in the Pleistocene" version of events.

    An important property of adaptive evolution is that it is usually a slow process. Certainly there are cases where a single genetic change can mean the difference between life and death in a hostile environment. The classic cases are the mutations that give pathogenic microorganisms the ability to resist antibiotics or mutations that allow crops to resist pathogens, for example insects or herbicides. But these are not representative models for how species adapt, by accumulation of mutations of small effect, to changes in food availability, temperature modifications, and the thousand shocks that flesh is heir to. The usual small differences in fitness among genotypes are therefore manifest as detectable evolutionary change only after thousands of generations.

    This deliberate tempo has presented the human species with a problem of adaptation. With a human generation of about twenty-five years, there have been roughly only one hundred generations since the founding of the Roman Republic. Yet the changes in the human environment caused by changes in human activity have been enormous. Changes in diet, habitation, working conditions, the pollution of air and water, and especially the considerable increase of lifespan that result in major alterations and breakdowns in the bodily machinery have all been too rapid for genetic adaptation.

    Notice the false premises: Adaptive evolution is "usually a slow process." Species adapt by "accumulation of mutations of small effect." It's as if he were transported back in time to 1908 where no one had heard of the breeder's equation.

    There's nothing impossible about long series of small changes. But they are not the only mode of adaptation, or even the most likely one. Populations with additive genetic variation that correlates with fitness will change rapidly under selection. The structure of the additive variation may lead to strong selection on one gene of large effect, or selection in parallel across many genes of varying effects. Series of small changes may be required for some adaptations, but a rapid environmental change (as Lewontin observes for humans) may cause bursts of rapid changes in allele frequencies.

    To maintain the slowness of human evolution, Lewontin must do three things:

    1. Assume humans are genetically uniform.

    2. Where humans obviously are not uniform, argue that variations are uncorrelated with fitness.

    3. Ignore any historical or genetic evidence that might contradict 1 and 2.

    Keeping in mind the short length of this section of the essay, Lewontin does manage all three of these conditions.

    I think it's downright sneaky the way Lewontin reinforces the assumption of human genetic uniformity. He refers to "the human genotype" as if there were only one! By emphasizing that "parts of the human genome are out of correspondence with modern life", he precludes the possibility that some human genomes may be more in correspondence than others. Sure, if humans share a single genome, they can't possibly differ in any adaptive way.

    But diversity is the reality. Examples of recent human evolution are fixtures in biology textbooks, from sickle-cell to lactase persistence. These are traits that have rapidly changed in frequency during the last 2500 years, due to changes in recent human environments -- disease for the former, diet for the latter. These rapid transformations in precisely those that Lewontin says are impossible -- environmental changes being "too rapid for genetic adaptation." A number of morphological changes are also evident when comparing archaeological and recent skeletal samples in many parts of the world. Somehow the relevance of these recent changes goes unmentioned in the essay.

    One of the best-characterized examples of evolution in recent populations is the rapid Holocene evolution of pigmentation phenotypes. It's a textbook example of human variation, and several adaptive hypotheses may explain it. So pigmentation would seem an unlikely example of how human evolution has been too slow to cope with the environment. But Lewontin finds a way:

    [H]igh doses of solar radiation that is experienced by surfers on the California beaches might induce an eventually fatal skin cancer, but the cancer death almost always occurs well after reproductive age, so there is no opportunity for selection to act.

    I agree that current patterns of cancer mortality of light-skinned surfers may have little impact on their fitness. In other words, this chronic disease is a sign of an environmental "mismatch" that future genetic evolution is unlikely to erase.

    But why turn to false arguments about the speed of evolution to make this point? Surely Lewontin knows that "reproductive age" in humans is not synchronous with reproductive effort? Skin cancer is one of the earliest-killing cancers, with a good fraction of victims dying at ages when they might otherwise be helping raise their kids or grandchidlren. Lewontin must also know that human populations vary greatly in their skin cancer susceptibility, and that some surfers (the dark pigmented ones) have lower skin cancer rates after the same sun exposure. Skin cancer may or may not be the best explanation for dark pigmentation in low-latitude human populations (there are others, none mutually exclusive), but this example works strongly against Lewontin's claims that natural selection is "slow" and that human environmental changes have been "too rapid for genetic adaptation." We aren't perfectly adapted today, and the rate of our evolution in the recent past was very fast.

    References:

    Lewontin RC. 2009. Why Darwin? New York Review of Books 56(9) May 28, 2009. Online

Pages

Subscribe to disease

Neandertals

For years, I've worked on their bones. Now I'm working on their genes. Read more about the science studying these ancient people.

Denisova

From a finger bone of an ancient human came the record of a completely unexpected population. My lab is working on the science of the Denisova genome.

Acceleration

The advent of agriculture caused natural selection to speed up greatly in humans. We're uncovering some of the ways that populations have rapidly changed during the last 10,000 years.

Malapa

Just outside Johannesburg, the Malapa site is producing some of the most exciting finds in human evolution. This site is the headquarters of the Malapa Soft Tissue Project.